Neurotrophic tyrosine receptor kinase (NTRK) fusions are validated oncogenic drivers of various adult and pediatric tumor types, including NTRK1, NTRK2, and NTRK3, which encode the TRK proteins TRKA, TRKB, and TRKC, respectively (3). The gene discussed is NTRK1; the disease is neoplasm.